http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
윤서구,김종홍,우제홍 대한화학요법학회 1991 대한화학요법학회지 Vol.9 No.2
Carumonam, a new monobactam antibiotic obtained by chemical modification of a monocyclic β-lactam sulfazecin, was adminstered to 30 patients with surgical infection, including 14 with acute appendicitis, 7 with acute or subacute cholecystitis and cholangitis, 6 with postoperative infections(2 with wound infection, 2 with enterocutaneous fistula, 1 with intraabdominal abscess and 1 with pneumonia), 2 with perianal abscess and 1 with intraabdominal abscess from May to Jul 1991. Carumonam was administered intravenously 2gm or 3gm a day in 2 or 3 divided dose for 3∼16 days. Appropriate therapy with antibiotics active against gram positive and/or anaerobic organism was administered concomitantly for mixed pathogen infections. Clinical responses were excellent in 9, good in 14, fair in 6 and poor in 1 patient, the overall efficacy being 76.7%(23 of 30 patients). the eradication rate of isolated organism was 79.5%, Side effect occurred in 1 case but not serious, and in the laboratory findings, elevations of GPT, ALP or BUN were noted in 5 cases. Carumonam is effective for the treatment of surgical infection due to susceptible gram negative bacteria and combination therapy with antibiotics active against gram positive and/or anaerobic organisms should be considered in surgical field.